Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Corbus Pharmaceuticals Holdings, Inc. - Common Stock (NQ:CRBP)

6.716 -0.704 (-9.49%)
Streaming Delayed Price Updated: 9:48 AM EDT, May 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Corbus Pharmaceuticals Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Bearish Monday For Marijuana Stocks - Maple Leaf Green World, 22nd Century Group Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For May 2, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From May 1, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For April 28, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For April 25, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 24, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 23, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 22, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 21, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For April 18, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 17, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 16, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Tuesday For Marijuana Stocks - Rocky Mountain High, Cara Therapeutics Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 11, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 8, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 2, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 1, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For March 28, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For March 24, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For March 18, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 17, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types. 
Via Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 23, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For October 21, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 21, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From October 9, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For October 8, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From October 4, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.